На главную
Результаты поиска “Niddk centers for diabetes translation research”
NCAI Diabetes Translation Webinar Series - Part 1
 
59:47
Date: November 22, 2013 Presentation: "Cultural Humility: A Core Value for American Indian Community Engagement and Translational Research" The NCAI Diabetes Translation Webinar Series features insights on how to improve diabetes translation research in American Indian and Alaska Native contexts. Topics include cultural humility; tribal and urban research regulation; policy advocacy; and co-occurring conditions. These webinars will be archived and linked as part of NCAI's Translation Guide for Diabetes Research in American Indian and Alaska Native Contexts that will be accessible on http://cdtr.wustl.edu and http://www.ncai.org/policy-research-center in 2014. This work has been developed under the Washington University in St. Louis Center for Diabetes Translation Research and made possible by Grant Number 1P30DK092950 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIDDK. Presenters: Dr. Tassy Parker (Seneca), Institute for Indigenous Knowledge and Development, University of New Mexico
Просмотров: 377 National Congress of American Indians
NCAI Diabetes Translation Webinar Series - Part 2
 
01:06:04
Date: November 26, 2013 Presentation: Native American Issues of Health: Translating pathways of health research, sovereignty, and philosophy into a community context The NCAI Diabetes Translation Webinar Series features insights on how to improve diabetes translation research in American Indian and Alaska Native contexts. Topics include cultural humility; tribal and urban research regulation; policy advocacy; and co-occurring conditions. These webinars will be archived and linked as part of NCAI's Translation Guide for Diabetes Research in American Indian and Alaska Native Contexts that will be accessible on http://cdtr.wustl.edu and http://www.ncai.org/policy-research-center in 2014. This work has been developed under the Washington University in St. Louis Center for Diabetes Translation Research and made possible by Grant Number 1P30DK092950 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIDDK. Presenter: Dr. Rodney Haring, University of Arizona
Просмотров: 766 National Congress of American Indians
Improving Your Negotiating Skills
 
57:35
Navigating The Academic Roadmap: A Lecture Series Designed for Junior Faculty The goal of this series is to help junior faculty achieve success in their academic trajectory through lectures and discussions. This series will cover the listed topics and is designed for both clinicians and basic scientists. Speaker: Carol M. Mangione, M.D., MSPH Carol M. Mangione, MD, MSPH, is the Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair and Professor of Medicine and Health Services at UCLA. Dr. Mangione is the Director of the NIH/NIA funded UCLA/Drew Resource Center for Minority Aging Research/Center for Health Improvement of Minority Elderly (RCMAR III/CHIME II), and Co-director of the UCLA Robert Wood Johnson Clinical Scholars Program. In both of these programs she mentors and trains physicians developing research careers. Dr. Mangione is the principal investigator for the Translational Research Centers for Diabetes Within Managed-Care Settings (TRIAD) Legacy study, funded by the Centers for Disease Control (CDC) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to study the quality of care for persons with diabetes where her work has focused on the relationship between organization of care, cost sharing, control of cardiovascular risk factors and process outcomes such as adherence to medications. Dr. Mangione is also principal investigator of the Agency for Healthcare Research and Quality (AHRQ) Virtual Lab for California Project.
Просмотров: 220 David Geffen School of Medicine UCLA
Global Diabetes Symposium, 7 of 12: Promoting Self-management Behaviors
 
18:07
http://www.einstein.yu.edu - Elizabeth Walker, Ph.D., RN, director of Prevention and Control Core for the Diabetes Research and Training Center at Albert Einstein College of Medicine, discusses self-management behaviors for the treatment of diabetes. She presented her talk at the Global Diabetes Symposium: Finding the Way to Global Action. The event, presented by Einstein's Global Health Center and the International Diabetes Federation, took place September 18, 2011.
Просмотров: 182 Albert Einstein College of Medicine
Sugar and the beating heart: the conundrum of heart failure in diabetes
 
01:02:51
Sugar and the beating heart: the conundrum of heart failure in diabetes Air date: Wednesday, February 7, 2018, 3:00:00 PM Category: WALS - Wednesday Afternoon Lectures Runtime: 01:02:50 Description: NIH Director’s Wednesday Afternoon Lecture Series Dr. Abel is internationally recognized for his research on the molecular mechanisms responsible for cardiac dysfunction in obesity, type 2 diabetes, and type 1 diabetes, and for studies of the role of mitochondrial dysfunction in the development of insulin resistance, obesity, and its complications. Dr. Abel earned his medical degree with distinction from the University of the West Indies in Kingston, Jamaica. He was a Rhodes Scholar and clinical research fellow with Professor John G. Ledingham at the University of Oxford, England, where he also earned a Ph.D. in physiology. He completed an internship and residency in medicine at McGraw Medical Center, a part of Northwestern University Medical School, where he served as chief resident of internal medicine at the VA Lakeside Medical Center. He was a clinical and research fellow and instructor at Harvard Medical School before joining the faculty at the University of Utah in 2000. Dr. Abel has earned many awards including the Van Meter Prize of the American Thyroid Association in 2001 and the 2012 Gerald D. Aurbach Award, from The Endocrine Society for "outstanding" contributions to endocrine research. He was elected Chair of the Board of Scientific Counselors of the NIH National Institute of Diabetes and Digestive and Kidney Diseases, and now serves as a member of the advisory council of the National Heart, Lung, and Blood Institute. He was chair of the Sarnoff Cardiovascular Research Foundation's Scientific Committee from 2012 to 2013, and is a fellow of the American Heart Association and the American College of Physicians. He was recently elected as president of the Endocrine Society. Dr. Abel is an elected member of the American Society for Clinical Investigation, American Clinical and Climatological Association, and the Association of American Physicians. He was elected to the National Academy of Medicine in October 2015. For more information go to https://oir.nih.gov/wals/2017-2018/sugar-beating-heart-conundrum-heart-failure-diabetes Author: E. Dale Abel, M.D., Ph.D., Francois M. Abboud Chair in Internal Medicine and John B. Stokes Chair in Diabetes Research; Chair and Department Executive Officer, Department of Internal Medicine, University of Iowa, Carver College of Medicine Permanent link: https://videocast.nih.gov/launch.asp?23703
Просмотров: 848 nihvcast
Physical Activity: Making Sense of Current Research, Persistent Myths, and Common Barriers
 
54:59
Webinar Speakers: - Dr. Jessica Unick, PhD, Assistant Professor (Research), Brown University Medical School - Leslie Curtis, MA, Director, Weight-control Information Network NIDDK, National Institutes of Health Learning objectives - attendees will better be able to: - Identify and understand the national physical activity guidelines - Recognize several common physical activity myths - Acknowledge barriers to physical activity participation and develop strategies to help patients overcome these barriers - Identify physical activity web content and tools from NIDDK and other sources For more information, visit https://www.niddk.nih.gov/
Global Diabetes Symposium, 10 of 12: The AMPATH Story
 
29:42
http://www.einstein.yu.edu - Sonak Pastakia, Pharm.D., M.P.H., B.C.P.S., assistant professor of pharmacy practice at Purdue University College of Pharmacy and Co-chair, AMPATH Chronic Disease Management Program, presents at the Global Diabetes Symposium: Finding the Way to Global Action. The event, presented by Global Health Center at Albert Einstein College of Medicine and the International Diabetes Federation, took place September 18, 2011. Subscribe:
Просмотров: 362 Albert Einstein College of Medicine
Grassroots Health: Communities Paying it Forward
 
03:09
Starting with African American churches and community leaders in Connecticut, medical expert David L. Katz wants to put the findings of the Diabetes Prevention Program to work in every town in America. Topic: The Diabetes Prevention Program.   David Katz: One example of the kinds of programs and the power that we have coming from the research community is the diabetes prevention program. The diabetes prevention program took 3,500 or so adults with pre-diabetes, so we're really on diabetes' doorstep, and randomly assigned them to one of three treatments: usual care, drug treatment with a drug called Metformin or Glucophage, and the lifestyle intervention arm. And this study was funded by the NIDDK which is one of the institutes at the National Institutes of Health, or NIH, to the tune of 174 million dollars; big study, important study. It was stopped early after 4 years because the results were so dramatic. 3,500 adults who were going to get diabetes soon. The drug worked very well. It actually prevented diabetes in 30% of those high risk adults; so almost one in three, who would've gotten diabetes without that treatment didn't. Pretty good. The lifestyle intervention however, prevented diabetes in 58%. It was twice as good. Now what was this? Was this some very creative diet? Only eat rutabaga under the light of the full moon while standing on one foot? Balanced, sensible nutrition: eat food, not too much, mostly plants, a healthy diet ala Michael Pollan, modern physical activity on a daily basis, modest weight loss -- translated into a 58% reduction in the occurrence of diabetes. A clear indication of the power of lifestyle over health. The challenge now and many people are working on this, is the development of the community-based programs that will translate what we learned in the diabetes prevention program and put it to work in every town in America. How do we make this play in Peoria? Or New Haven, Connecticut where I come from? Or any other town? So in our case, we took that program which clearly is the best practice, there's an educational program attached to the DPP. We said if we can find an inexpensive way to make this infiltrate the community, maybe we can see some of those gains in diabetes prevention where we live. So we developed a program called "PREDICT -- Partners Reducing the Effects of Diabetes Initiatives through Collaboration and Teamwork." This was funded by the centers for disease control. We worked with African-American churches in New Haven and Bridgeport, Connecticut, to identify leaders in the congregation in the community who would become pure educators. So we trained them in diabetes prevention. We taught them the lifestyle arm of the diabetes prevention program and then we said "Pay it forward. You know your community. People listen to you. People respect you. If you care about this and you're knowledgeable, you can reach people that we probably can't." Coming from academia, they distrust us. You really need to be part of community.   Recorded on: July 06, 2009
Просмотров: 78 Big Think
UTHSC: Science as a Tool for Justice
 
01:14:29
Full Story Here: http://nowcastsa.com/blogs/webcast-science-tool-justice Science: A Tool for Justice, presented by Griffin P. Rodgers, M.D., MACP, director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Common, chronic, costly and consequential diseases - including type 2 diabetes, obesity, kidney disease and liver disease - disproportionately affect people of color. Biomedical research offers tremendous opportunity to reduce the impact of health disparities, in effect harnessing the power of science as a tool for justice. Equally important are translation efforts to see if research findings are scalable and can be brought to at-risk populations.
Просмотров: 44 NOWCastSA
The Bigger Picture: Countdown by QueenNefertiti
 
03:02
QueenNefertiti Shabazz created a piece that talks about how stress leads us to make bad decisions that affect our health and in turn our ability to function. Filmed and edited by Dimitri Moore of DWM Producing with creative contributions by Hodari Davis, Sarah Fine and Jose Vadi. Youth Speaks and UCSF Center for Vulnerable Populations are leading the campaign against Type 2 Diabetes with our new project, The Bigger Picture. Raise your voice TODAY! http://www.TheBiggerPicture.org http://www.twitter.com/BigPicCampaign * Naryan KM, Boyle J, et. Al. Lifetime Risk for Diabetes Mellitus in the United States. AMA. 2003;290 (14):1884-1890. * Narayan KM. CDC issues diabetes warning for children. ADA Meetings. New Orleans, La; June 14, 2003. * Tami MacAller. California Diabetes Program – California Center for Physical Activity * Bergmann , N, et al. (2014). The appraisal of chronic stress and the development of the metabolic syndrome: a systematic review of prospective cohort studies. Endocrine Connections. * Tsiouli, Elina, et al. (2013). Effects of diabetes-related family stress on glycemic control in young patients with type 1 diabetes: Systematic review. Can Fam Physician; 59(2): 143–149. * Detka, Jan, et al. (2013). Neuroendocrine link between stress, depression and diabetes. Pharmacological Reports; 65(6):1591-600. * National Institute of Diabetes and Digestive and Kidney Diseases; Diabetes Prevention Program http://diabetes.niddk.nih.gov/dm/pubs/preventionprogram/
Просмотров: 3252 Youth Speaks
Using EHR Data and Clinical Decision Support Tools
 
01:00:10
Speaker: Rachel Gold, Ph.D., MPH Assistant Investigator , Kaiser Permanente Center for Health Research Description: Integrated health care organizations such as Kaiser Permanente (Kaiser) have developed clinical decision support systems (CDSS) that harness EHR data to improve provider adherence to guideline-based prescribing. For example, Kaiser's diabetes quality improvement intervention, the 'ALL Initiative,' uses EHR-based CDSS tools to improve rates of guideline-based cardio-protective prescribing. To assess whether this effective intervention could be adapted for use in CHCs, we conducted a 'translational' randomized trial involving11 CHCs in Portland, OR. We adapted Kaiser's intervention elements for the CHC context, implemented the adapted CDSS tools in the study CHCs, and assessed how the tools impacted rates of guideline-based prescribing. We found that we needed to substantially adapt the EHR-based tools to provide the CHCs with functions equivalent to Kaiser's; we also identified and addressed a number of challenges to integrating the tools into the CHCs' workflows. Despite these challenges, implementing the 'ALL Initiative' CDSS tools was associated with significant improvements in care quality. Our results illustrate the challenges involved in using EHR-based tools to support practice change and quality improvement efforts in CHCs.
Просмотров: 2321 NIHOD
Research Directions in Stevens-Johnson Syndrome Toxic Epidermal Necrolysis - Teri Manolio
 
01:00:32
September 21, 2015 - National Advisory Council for Human Genome Research More: http://www.genome.gov/27562458
Просмотров: 883 National Human Genome Research Institute
TRACO 2017 - Clinical trials and Precision Medicine
 
02:00:08
TRACO 2017 - Clinical trials and Precision Medicine Air date: Monday, September 11, 2017, 4:00:00 PM Category: TRACO Runtime: 02:00:08 Description: Translational Research in Clinical Oncology (TRACO) Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation sequencing, genomics and proteomics. For more information go to http://ccr.cancer.gov/trainee-resources-courses-workshops-traco Author: Jill Smith, MD, Georgetown University and Curtis C. Harris, M.D., NCI, NIH Permanent link: https://videocast.nih.gov/launch.asp?23453
Просмотров: 901 nihvcast
A New Look at Peripheral Tolerance, or, Good Genes Behaving Badly
 
01:11:21
Air date: Wednesday, March 14, 2012, 3:00:00 PM Time displayed is Eastern Time, Washington DC Local Category: Wednesday Afternoon Lectures Description: Understanding the pathogenesis of T1D should facilitate the development of novel disease biomarkers and therapeutics that can accomplish a stated goal of NIDDK, to block T1D progression before complete  cell destruction. The major emphasis placed on disease associated genetic mutations or polymorphisms to understand the genetics of T1D has failed to advance either understanding of T1D pathogenesis or to identify therapeutic targets. Recent studies from the Fathman lab have demonstrated that tissue- and disease-specific changes in mRNA expression, rather than DNA variants, may underlie the progression of T1D. Work to be presented emphasizes the importance of studying the control of tissue-specific gene expression in relationship to the pathogenesis of T1D. By combining their expertise in T1D research with their established preclinical models and patient samples/tissues from their collaborator, the Network for Pancreatic Organ Donors with Diabetes, nPOD http://www.jdrfnpod.org, Fathman and colleagues have both demonstrated a potential defect in peripheral tolerance in NOD mice that has homologies in T1D patients and have demonstrated that appropriate immunotherapy may overcome this defect The NIH Wednesday Afternoon Lecture Series includes weekly scientific talks by some of the top researchers in the biomedical sciences worldwide. For more information, visit: The NIH Director's Wednesday Afternoon Lecture Series Author: C. G. (Garry) Fathman, MD, Stanford University School of Medicine Runtime: 01:11:21 Permanent link: http://videocast.nih.gov/launch.asp?17165
Просмотров: 1792 nihvcast
Leptin and the neural circuit regulation food intake and glucose metabolism
 
57:40
Leptin and the neural circuit regulation food intake and glucose metabolism Air date: Wednesday, January 11, 2017, 3:00:00 PM Category: WALS - Wednesday Afternoon Lectures Runtime: 00:57:39 Description: NIH Director’s Wednesday Afternoon Lecture Series The discovery of leptin has led to the elucidation of a robust physiologic system that maintains fat stores at a relatively constant level. Leptin is a peptide hormone secreted by adipose tissue in proportion to its mass. This hormone circulates in blood and acts on the hypothalamus to regulate food intake and energy expenditure. When fat mass falls, plasma leptin levels fall stimulating appetite and suppressing energy expenditure until fat mass is restored. When fat mass increases, leptin levels increase, suppressing appetite until weight is lost. By such a mechanism, total energy stores are stably maintained within a relatively narrow range. Recessive mutations in the leptin gene are associated with massive obesity in mice and some humans. Treatment with recombinant leptin markedly reduces food intake and body weight. The low leptin levels in patients with leptin mutations are also associated with multiple abnormalities including infertility, diabetes, and immune abnormalities all of which are corrected by leptin treatment. These findings have established important links between energy stores and many other physiologic systems and led to the use of leptin as a treatment for an increasing number of other human conditions including a subset of obesity, some forms of diabetes including lipodystrophy and hypothalamic amenorrhea, the cessation of menstruation seen in extremely thin women. Identification of a physiologic system that controls energy balance establishes a biologic basis for obesity. Recent studies have explored the relationship between leptin and the reward value of food. In addition, new methods for identifying neurons activated by leptin and other stimuli have been developed as have methods for noninvasively activating cells using radio waves. These new approaches are being applied to studies of the neural processes that control feeding, a complex motivational behavior. For more information go to https://oir.nih.gov/wals Author: Jeffrey Friedman, M.D., Ph.D., Professor, The Rockefeller University; Director, Starr Center for Human Genetics; Investigator, Howard Hughes Medical Institute Permanent link: https://videocast.nih.gov/launch.asp?21075
Просмотров: 10505 nihvcast
Opportunities and Challenges for Health Disparities Research in the Personal Genome Era
 
01:07:08
May 27, 2015 - Genomics and Health Disparities Lecture Series Speaker: Carlos Bustamante More: http://www.genome.gov/27561525
Просмотров: 2230 National Human Genome Research Institute
IRP Neuroscience Webinar (Part 3) - Anand Swaroop, NIH Scientist
 
18:01
"Between Thought and Therapy: Translating Neurobiology Research into Treatments" (Part 3, featuring Dr. Anand Swaroop) This webinar explores how translational neurobiology research is being conducted in the Intramural Research Program (IRP) of the National Institutes of Health (NIH), in disorders as diverse as depression, age-related macular degeneration, and Gaucher's disease. Our panelists all conduct translational research across the full bench-to-bedside continuum, with the ultimate goal of developing novel paradigms for the treatment of a range of diseases and improving quality of life for patients. Anand Swaroop, Ph.D., is Senior Investigator in the Retinal Development, Genetics, and Therapy Section at the National Eye Institute. For more information about Dr. Swaroop's work visit http://irp.nih.gov/pi/anand-swaroop Our expert panel will: • Share their experiences of applying basic research at the bedside • Discuss the best environments for conducting translational research • Provide advice on working in new experimental systems, such as stem cells To view the original webinar format: http://webinar.sciencemag.org/webinar/archive/between-thought-and-therapy The IRP is the internal research program of the NIH, known for its synergistic approach to biomedical science. With 1,200 principal investigators and more than 4,000 postdoctoral fellows conducting basic, translational, and clinical research, the IRP is the largest biomedical research institution on Earth. Its unique funding environment means the IRP can facilitate opportunities to conduct both long-term and high-impact science that would otherwise be difficult to undertake.
Demystifying Medicine 2017: Addiction and Habituation: Drugs and Food
 
01:40:27
Demystifying Medicine 2017: Addiction and Habituation: Drugs and Food Air date: Tuesday, January 17, 2017, 4:00:00 PM Category: Demystifying Medicine Runtime: 01:40:27 Description: The Demystifying Medicine Lecture Series is designed to help bridge the gap between advances in biology and their applications to major human diseases. Each lecture will feature a presentation on a major disease, including current research and advancements on treatments. For more information go to https://demystifyingmedicine.od.nih.gov/ Author: Nora Volkow, MD, PhD, NIDA, NIH and Kevin Hall, PhD, NIDDK, NIH Permanent link: https://videocast.nih.gov/launch.asp?21083
Просмотров: 1898 nihvcast
Demystifying Medicine 2017: Obesity: Brown and Other Fat
 
01:30:01
Demystifying Medicine 2017: Obesity: Brown and Other Fat Air date: Tuesday, March 28, 2017, 4:00:00 PM Category: Demystifying Medicine Runtime: 01:30:01 Description: The Demystifying Medicine Lecture Series is designed to help bridge the gap between advances in biology and their applications to major human diseases. Each lecture will feature a presentation on a major disease, including current research and advancements on treatments. For more information go to https://demystifyingmedicine.od.nih.gov Author: Aaron Cypess, MD, PhD, MMSc, NIDDK, NIH and Rebecca Brown, MD, MHSc, NIDDK, NIH Permanent link: https://videocast.nih.gov/launch.asp?22202
Просмотров: 1788 nihvcast
Cancer, Diabetes, and Oral Health Disparities in American Indian/Alaska Native Communities
 
01:20:07
NIH-sponsored researchers Drs. Dedra Buchwald, Rob Nelson, and Terry Batliner explain the burden of several diseases (cancer, diabetes, and oral disease) among American Indians and Alaska Natives in this Nov 8, 2012, webinar. For more information, please visit the National Cancer Institutes site at: www.cancer.gov/mmo-webinars.
Просмотров: 917 NCIwebinars
2017 ODP Early-Stage Investigator Award Winners Lectures
 
53:58
The ODP Early-Stage Investigator Award recognizes early-stage career scientists who have already made significant contributions to prevention. The 2017 winners, Dr. Justin Brown and Dr. Katherine Keys, gave presentations at the National Institutes of Health (NIH) on Wednesday, May 3, 2017. Dr. Brown discusses “A Phase II Randomized Clinical Trial to Evaluate the Dose-Response Effects of Exercise on Prognostic Biomarkers among Colon Cancer Survivors.” Dr. Keys’ presentation is titled “Alcohol use and morbidity across historical time: What does variation tell us about environmental determinants of alcohol-related outcomes?”
Просмотров: 183 NIH ODP
NHLBI Small Biz Hangout: Demystifying Small Business Review
 
59:57
NIH Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) grant applications and contract proposals go through a multi-level system of review: scientific peer review and advisory council review. This NHLBI Small Biz Hangout explains the NIH scientific peer review process, differences between types of funding opportunities and where they are reviewed, and how you can participate in the peer review system. Presenters: Dr. Margaret Chandler from the NIH Center for Scientific Review (CSR) and Dr. Kristin Goltry from the NHLBI Office of Scientific Review. Hosted by Dr. Jennifer Shieh from the NHLBI Office of Translational Alliances and Coordination. Chapter 1: NHLBI Office of Translational Alliances and Coordination 05:05 Chapter 2: Overview of the NIH Small Business Peer Review Process 6:07 Chapter 3: The NIH Center for Scientific Review 12:40 Chapter 4: Get Your Application to the Right Study Section 18:23 Chapter 5: Center for Scientific Review Helpful Links 31:30 Chapter 6: Q&A 32:05 Chapter 7: Peer Review at the NHLBI 38:41 Chapter 8: Final Q&A 48:18
Просмотров: 275 NHLBI
mHealth-Enhanced Support from Informal Caregivers Improves Medication Adherence
 
01:09:16
Speaker: James E. Aikens, Ph.D. Associate Professor of Department of Family Medicine and Faculty Affiliate, Center for Managing Chronic Disease University of Michigan, Ann Arbor, MI Description: Although telemonitoring-assisted care management improves outcomes in many chronic conditions, creative strategies are needed to overcome logistical limitations in available personnel, health care finances, and technical support. Additionally, patients' in-home caregivers are often overburdened, prone to burnout, and coping with their own medical conditions. Recent and ongoing projects at the University of Michigan (Center for Center for Managing Chronic Disease, and the Department of Family Medicine) have used mobile health (mHealth) technologies to enable informal caregiver from outside the patient's home to support their medication adherence and self-management in real time. In this mHealth system, patients with diabetes, heart failure, or depression undergo weekly automated telephonic health assessments during which they hear problem-tailored messages about adherence and self-management. Their informal caregiver (a designated close friend or family member from outside their home) receives corresponding guidance on how to support the patient's self-management, while their clinician is notified about any medically-urgent situations. Our preliminary trials show that, compared to basic telemonitoring, incorporating informal caregivers into this system enhances medication adherence and illness self-management behaviors. If ultimately shown effective in our ongoing NIH-funded RCTs, then these and similar mHealth programs could be broadly implemented, have major public health impact, and be expanded to simultaneously address multiple chronic conditions.
Просмотров: 270 NIHOD
Demystifying Medicine 2016: Non Alcoholic Fatty Liver Disease and Steato-Hepatitis (NAFLD/ NASH)
 
01:28:44
Demystifying Medicine 2016: Non Alcoholic Fatty Liver Disease and Steato-Hepatitis (NAFLD/ NASH): an “epidemic” liver disease requiring new drugs Air date: Tuesday, March 15, 2016, 4:00:00 PM Category: Demystifying Medicine Runtime: 01:28:44 Description: Demystifying Medicine is an annual course from January to May designed to help bridge the gap between advances in biology and their application to major human diseases. The course includes presentation of patients, pathology, diagnosis, and therapy in the context of major disease problems and current research, primarily directed toward Ph.D. students, fellows, and staff. All are invited. For more information go to https://demystifyingmedicine.od.nih.gov/ Author: Yaron Rotman, MD, MSc, NIDDK, NIH and Rosana Kapeller, MD, PhD, Nimbus Therapeutics Permanent link: http://videocast.nih.gov/launch.asp?19554
Просмотров: 2611 nihvcast
Demystifying Medicine 2014 - Obesity: Etiology, Pathogenesis and Why Weight Loss is Difficult
 
01:51:30
Demystifying Medicine 2014 - Obesity: Etiology, Pathogenesis and Why Weight Loss is Difficult Air date: Tuesday, February 04, 2014, 4:00:00 PM Runtime: 01:51:29 The 2014 Demystifying Medicine Series, which is jointly sponsored by FAES and NIH, will begin January 7th and includes the presentation of patients, pathology, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students, clinicians and program managers, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students, fellows and staff are welcome, as well. For more information go to http://demystifyingmedicine.od.nih.gov Author: Jack Yanovski, MD, PhD (NICHD) Kevin Hall, PhD (NIDDK) Permanent link: http://videocast.nih.gov/launch.asp?18266
Просмотров: 3028 nihvcast
Demystifying Medicine 2013 - Hepatitis B and the T Cell
 
01:38:04
Hepatitis B and the T Cell - Using Human Genetics to Decipher the Host Response Against Viral Pathogens The Demystifying Medicine Series includes the presentation of patients, pathology, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students, clinicians and program managers, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students, fellows and staff are welcome, as well. Tuesday, January 29, 2013 Jay Hoofnagle, MD (NIDDK) and Michael Lenardo, MD (NIAID) Permanent link: http://videocast.nih.gov/launch.asp?17776
Просмотров: 1249 nihvcast
SPARC Strategic Planning Workshop: Biology & Technology (Day 1)
 
07:49:27
SPARC Strategic Planning Workshop: Biology & Technology (Day 1) Air date: Wednesday, February 25, 2015, 8:00:00 AM Category: Advisory Board Meetings Runtime: 07:49:26 Description: The SPARC Biology and Technology Workshop bring together disparate research communities to assess the following: The current status of functional and anatomical mapping of peripheral innervation in organs. The opportunities for additional knowledge and technologies that would be foundational for understanding neuronal control of organ and organ system function in animal models and humans. Furthermore, this workshop will help elucidate technical and biological opportunities within and across communities in a variety of organs and conditions. For more information go to http://www.scgcorp.com/sparc2015/Default Author: NIH-OD/DPCPSI/Office of Strategic Coordination Permanent link: http://videocast.nih.gov/launch.asp?18869
Просмотров: 829 nihvcast
July 2017 Meeting of the Advisory Council on Alzheimer’s Research, Care, and Services Part 3
 
01:26:49
This is the quarterly meeting of the Advisory Council on Alzheimer’s Research, Care, and Services. For more information, please visit https://aspe.hhs.gov/national-alzheimers-project-act
Methods and Techniques for Integrating Biological Variable Sex in Preclinical Research - PM
 
03:55:13
One of the fundamental variables in preclinical biomedical research is sex: whether a cell, tissue, or animal is female or male. Biological sex is an important consideration for this research that underlies drug development, clinical trials, and prevention approaches. Learn how to incorporate sex to strengthen scientific design from leaders in the field through this recorded full-day meeting hosted by the NIH Office of Research on Women’s Health. In this video covering the afternoon sessions, learn about practical methods to integrate the biological variable sex into research projects and cultivating a culture of “Sex Matters” across multiple disciplines. Concludes with recommendations and highlights.
Просмотров: 1064 NIHOD
Methods and Techniques for Integrating the Biological Variable "Sex" in Preclinical Research - PM
 
03:55:13
Methods and Techniques for Integrating the Biological Variable "Sex" in Preclinical Research Air date: Monday, October 20, 2014, 7:45:00 AM Category: Conferences Description: Office of Research on Women's Health The “Methods and Techniques for Integrating the Biological Variable Sex in Preclinical Research” workshop sponsored by the Office of Research on Women’s Health will focus on the incorporation of sex in basic science research studies. Session Topics will include: The rational for including male and female subjects in studies; the impact of including or not including sex as a basic biological variable; practical methods to integrate the biological variable “sex” into research projects; and how to cultivate a culture of “Sex Matters” across multiple disciplines. The workshop will include presentations from Dr. Lawrence Tabak, Deputy Director, NIH and Dr. Lawrence Cahill, Professor, University of California, Irvine. For more information go to http://orwh.od.nih.gov Author: Office of Research on Women's Health, NIH Permanent link: http://videocast.nih.gov/launch.asp?18686
Просмотров: 2648 nihvcast
NIMHD Vision and Agenda: Common Ground with NHGRI - Eliseo Perez-Stable
 
47:24
May 16, 2016 - National Advisory Council for Human Genome Research More: https://www.genome.gov/27564922/
Просмотров: 177 National Human Genome Research Institute
Chronic Kidney Disease - A Window into Understanding Health Disparities - Neil Powe
 
01:01:41
March 7, 2016 - Genomics and Health Disparities Lecture Series More: http://www.genome.gov/27561525
Просмотров: 1185 National Human Genome Research Institute
Regenerative Medicine: Current Concepts and Changing Trends
 
51:30
Air date: Wednesday, January 25, 2012, 3:00:00 PM Time displayed is Eastern Time, Washington DC Local Category: Wednesday Afternoon Lectures Description: Patients with diseased or injured organs may be treated with transplanted organs. There is a severe shortage of donor organs which is worsening yearly due to the aging population. Regenerative medicine and tissue engineering apply the principles of cell transplantation, material sciences, and bioengineering to construct biological substitutes that may restore and maintain normal function in diseased and injured tissues. Stem cells may offer a potentially limitless source of cells for tissue engineering applications and are opening new options for therapy. Recent advances that have occurred in regenerative medicine will be reviewed and applications of these new technologies that may offer novel therapies for patients with end-stage tissue and organ failure will be described. The NIH Wednesday Afternoon Lecture Series includes weekly scientific talks by some of the top researchers in the biomedical sciences worldwide. For more information, visit: The NIH Director's Wednesday Afternoon Lecture Series Author: Anthony Atala, M.D., Wake Forest School of Medicine Runtime: 00:51:29 Permanent link: http://videocast.nih.gov/launch.asp?17075
Просмотров: 11860 nihvcast
Demystifying Medicine 2016: How Long Can and Should We Live & What Centenarians Teach Us about Aging
 
01:44:40
Demystifying Medicine 2016: How Long Can and Should We Live & What Centenarians Teach Us about Aging Air date: Tuesday, May 17, 2016, 4:00:00 PM Category: Demystifying Medicine Runtime: 01:44:39 Description: Demystifying Medicine is an annual course from January to May designed to help bridge the gap between advances in biology and their application to major human diseases. The course includes presentation of patients, pathology, diagnosis, and therapy in the context of major disease problems and current research, primarily directed toward Ph.D. students, fellows, and staff. All are invited. For more information go to https://demystifyingmedicine.od.nih.gov Author: Luigi Ferrucci, MD, NIA, NIH and Nir Barzilai, MD, Albert Einstein College of Medicine Permanent link: http://videocast.nih.gov/launch.asp?19693
Просмотров: 690 nihvcast
Discovering the Full Super Powers of DSMES
 
01:19:38
In this 90-minute webinar, a panel of “wonder women” in diabetes education will discuss the four critical time points to assess, provide, and adjust diabetes self-management education/support. The webinar will also highlight a toolkit created by these national organizations to assist diabetes educators and others with sharing the information and recommendations included in the joint position statement. Webinar speakers will unravel the mystery of DSMES though a role-play showcasing tips to use this position statement to increase referrals to DSMES services. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at https://www.cdc.gov/diabetes/videos/Wonder-Women-Webinar-recording-MP4-low%20res.mp4 Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at https://www.cdc.gov/diabetes/videos/Wonder-Women-Webinar-recording-MP4-low%20res.mp4
Childhood Obesity and the Environment Virtual Forum
 
59:19
Dr. Birnbaum's Introduction 3:01 Questions: How do we define children's obesity? 5:04 How are chemicals affecting body weight? 6:00 What research has been conducted? 7:18 Where is there information about obesity rates? 8:24 Why is the Deep South off the charts for obesity? 9:17 What exposures and maternal factors may affect obesity? 9:59 Do prenatal exposures predestine a child to be obese? 10:47 What other illnesses are related? 11:38 What are contaminants in the home and school? 12:42 Is anyone looking at all the chemicals in daycares? 13:57 What elements can decrease childhood obesity? 15:14 Could obesity exacerbate asthma? 16:20 What opportunities are there for prevention? 17:41 What are the messages to parents and others? 19:40 Do resources match the severity of the problem? 22:57 Have there been studies about pesticides? 24:16 Is indoor dust a source of exposure? 24:48 Is lead still relevant in the U.S.? 25:37 What do we know about molecular mechanisms? 27:12 Is genetically modified food a contributor? 28:24 What is the impact of nutrition and diet? 30:47 Does the First Lady's Let's Move program go far enough? 32:56 What about multiple, complex exposures? 34:00 Is NIH research on obesity coordinated? 36:23 What's the role of built environment, activity, & social factors? 38:03 What changes can schools make to affect obesity? 40:17 Is obesity leveling off anywhere? 42:19 How is puberty related to body size? 44:09 What role does the chemical industry have? 45:21 How can communities become more involved? 48:15 Where do Polycyclic Aromatic Hydrocarbons come from? 49:17 What's the role of artificial coloring and flavorings? 50:25 What diseases might develop from early life exposures? 51:15 What about obesity and the depressed immune system? 54:21 Any ideas on getting physical education back into schools? 55:05 What's the contribution of chemicals relative to diet/lifestyle? 57:10 Originally aired 11-29-2012. (HD)
Просмотров: 1310 NIEHS
Demystifying Medicine 2015 - Sickle Cell Anemia: a Vicious Viscid Sickle Cycle
 
01:40:33
Demystifying Medicine 2015 - Sickle Cell Anemia: a Vicious Viscid Sickle Cycle Air date: Tuesday, April 14, 2015, 4:00:00 PM Category: Demystifying Medicine Runtime: 01:40:33 Description: The 2015 Demystifying Medicine Series, which is jointly sponsored by FAES and NIH, will begin January 6th and includes the presentation of patients, pathology, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students, clinicians and program managers, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students, fellows and staff are welcome, as well. For more information go to http://demystifyingmedicine.od.nih.gov Author: Alan Schechter, MD, NIDDK, NIH and Christopher Austin, MD, PhD, NCATS, NIH Permanent link: http://videocast.nih.gov/launch.asp?18947
Просмотров: 370 nihvcast
Heart Disease Risk Factors among African Immigrants Residing in the United States
 
58:04
In this webinar, Dr. Yvonne Commodore-Mensah, Assistant Professor at Johns Hopkins School of Nursing, gives an overview of what is known about heart disease risk factors among African immigrants residing in the United States, including: 1. The sociodemographic profile of African immigrants in the US 2. Current research on heart disease risk factors in African immigrant in the US 3. The role of acculturation on heart health 4. Clinical and public health strategies to improve the heart health of African immigrants in the US This webinar was originally held on August 11, 2017
Просмотров: 70 HHS Office of Minority Health
Demystifying Medicine 2014 - Drug-Induced Liver Injury: Who, What, When and How
 
01:53:19
Demystifying Medicine 2014 - Drug-Induced Liver Injury: Who, What, When and How Air date: Tuesday, March 18, 2014, 4:00:00 PM Category: Demystifying Medicine Runtime: 01:53:18 Description: The 2014 Demystifying Medicine Series, which is jointly sponsored by FAES and NIH, will begin January 7th and includes the presentation of patients, pathology, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students, clinicians and program managers, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students, fellows and staff are welcome, as well. For more information go to http://demystifyingmedicine.od.nih.gov Author: Leonard Seefe, MD (NIH/FDA Formerly) Chris Austin, MD (NCATS) Permanent link: http://videocast.nih.gov/launch.asp?18336
Просмотров: 3364 nihvcast
Fireside Chat on Implementation Science & Behavioral Research Program Crossroads
 
49:31
Since kicking off our ‘fireside chat’ format in late 2016, we have been joined via webinar by all manner of leading experts, collaborators, mid-career investigators, and colleagues from around NIH to discuss funding, training, growth in the field, global implementation science. In 2018 we are excited to welcome leaders from around DCCPS in discussion of the various research programs at the intersection of implementation science. Dr. David Chambers was joined by Dr. William Klein, Associate Director of the Behavioral Research Program (BRP) within DCCPS to discuss implementation science intersections with the BRP research portfolio. BRP initiates, supports, and evaluates a comprehensive program of research, including basic behavioral and psychological science as well as the development, testing, and dissemination of interventions in cancer control areas such as tobacco use, diet, and sun protection. Additionally, Drs. Chambers and Klein will touch on where IS and BRP staff are already building programs together, training initiatives, and future direction for collaboration. http://cancercontrol.cancer.gov/IS
Просмотров: 70 NCIwebinars
Working to end the HIV pandemic: Glimmers of Hope
 
01:00:49
Working to end the HIV pandemic: Glimmers of Hope Air date: Wednesday, September 19, 2012, 3:00:00 PM Category: Wednesday Afternoon Lectures Description: The Annual Rolla E. Dyer Lecture The efficiency of transmission of HIV-1 depends on the infectiousness of the index case and the susceptibility of those exposed. Infectiousness is dictated by the concentration of HIV-1 and the viral genotype and phenotype. People newly infected with HIV-1 (i.e. acute infection) and those with STD co-infections excrete such a large concentration of virus as to be "hyperinfectious". The probability of HIV-1 transmission may be as low as 1/10,000 episodes of intercourse or 1/10 sexual exposures when anal intercourse is practiced. The transmission of HIV is generally limited a small number of founder variants which themselves may be "hyperinfectious". Synergistic behavioral and biologic HIV prevention strategies have been developed and implemented. Safer sex includes limiting the number of sexual partners and use of male latex condoms, and these strategies appear to have contributed to reduced HIV-1 incidence in many countries. Biological interventions have proven catalytic: These include voluntary male circumcision and use of antiviral agents either for infected people (who can be rendered less contagious) or as pre- and post-exposure prophylaxis (PrEP and PEP). Ecologic evidence suggests that broader, earlier antiviral treatment of HIV may be reducing incidence in some (but not all) populations. However, maximal benefit of HIV "treatment for prevention" and application of PrEP will likely require a program of universal "test and treat", where many more infected patients are identified, linked to care, and treated very early in disease and for life. Community randomized trials designed to support this approach are underway in Africa. The "test and treat" prevention strategy is resource intensive and serves to emphasize the urgent need for even more research devoted to HIV-1 vaccine development, or cure of the infection. The NIH Wednesday Afternoon Lecture Series includes weekly scientific talks by some of the top researchers in the biomedical sciences worldwide. For more information go to http://wals.od.nih.gov Author: Myron S. Cohen, M.D., Institute of Global Health and Infectious Diseases, The University of North Carolina at Chapel Hill Runtime: 01:00:49 Permanent link: http://videocast.nih.gov/launch.asp?17570
Просмотров: 1151 nihvcast
TPEP Symposium - Understanding the Current State of Art (Session C)
 
02:16:24
“Session C: Understanding the Current State of the Art” from Day 2 of the Symposium on Accessibility & Development of Tissue Products for Emergency Preparedness held on May 11-12, 2015 at the National Archives, Washington, DC. 00:00:00 Discussion Leader Introduction • Narayan Iyer, PhD 00:06:35 “Allograft and Xenograft Products and Application” • Roger Yurt, MD 00:33:07 “Biosynthetic and Combination Products and Applications” • James Holmes, IV, MD, FACS 00:52:10 Panel C: Questions and Discussion with Dr. Yurt and Dr. Holmes 01:01:50 “Products in Development” 01:03:39 Stratatech Corporation • Lynn Allen-Hoffmann, PhD 01:13:39 Avita Medical • Andrew Quick, MS 01:28:29 Integra Lifesciences • Tom Tarca, MBA 01:41:21 Lonza, INC • Richard Kagan, MD, FACS 01:58:34 Panel C: Questions and Discussion with Dr. Allen-Hoffmann, Mr. Quick, Mr. Tarca, and Dr. Kagan -- U.S. Department of Health and Human Services (HHS) http://www.hhs.gov We accept comments in the spirit of our comment policy: http://www.hhs.gov/web/socialmedia/policies HHS Privacy Policy http://www.hhs.gov/Privacy.html
Purdue Public Health Symposium
 
02:12:15
Presenters address issues that fall within the Purdue Public Health Graduate Program's three concentrations: Family and Community Health; Environmental Health; and Health Statistics.
Просмотров: 1378 Purdue University
FEVS Dissemination Tool
 
01:53:43
Просмотров: 253 USOPM